Skip to main content

Find Clinical Trials

Home
Conditions
FLT3-TKD Mutation

Clinical trial condition

FLT3-TKD Mutation

Explore clinical trials studying FLT3-TKD Mutation. Study availability and eligibility vary by location and protocol.

2 public trials 1 recruiting study

Refine in advanced search Browse all conditions

FLT3-TKD Mutation trial results

Recruiting

Study Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilteritinib in Subjects ≥18 Years of Age With Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia

NCT06022003

Conditions: AML, Adult, FLT3-ITD, FLT3-TKD Mutation, +9 more
Locations: Amiens CHU Amiens, France

Angers CHU Angers, France

Hôpital d'Instruction des Armées PERCY Clamart, France

CHU Estaing Clermont-Ferrand, France

View all 20 locations

View Trial Details

Completed

A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE

NCT05193448

Conditions: FLT3-ITD, FLT3-TKD Mutation, Hematologic Diseases, +8 more
Locations: Amiens CHU Amiens, France

Angers CHU Angers, France

Avignon CH Avignon, France

Bayonne CH Bayonne, France

View all 38 locations

View Trial Details